Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Stimulants01:29

Stimulants

576
Stimulants are substances that enhance neural activity and elevate dopamine levels in the brain, leading to their highly addictive nature. These drugs include cocaine, amphetamines, MDMA, caffeine, and nicotine, each with distinct mechanisms of action and varied health implications.
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
576
Drugs Acting on Autonomic Ganglia: Stimulants01:23

Drugs Acting on Autonomic Ganglia: Stimulants

1.8K

Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating...
1.8K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

214
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
214
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

87
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
87
Stress Prevention and Stress Management Techniques IV01:26

Stress Prevention and Stress Management Techniques IV

94
Stress often leads to unhealthy habits like smoking, excessive drinking, and overeating, which offer short-term relief but ultimately increase long-term health risks. These behaviors create a cycle that temporarily lowers stress levels but can result in severe long-term health consequences. Breaking these habits is essential to reduce the risk of chronic diseases and improve overall well-being. Three primary changes that support better health include quitting smoking, reducing alcohol intake,...
94
CNS Depressants: Alcohol and Nicotine01:27

CNS Depressants: Alcohol and Nicotine

610
Ethanol, a clear colorless alcohol, has been consumed by humans for millennia, but its effects on the body are far from benign. At lower doses, it induces decreased inhibitions and loquaciousness, leading to its social appeal. However, it can cause severe consequences at higher doses, such as coma and respiratory depression, due to its zero-order elimination kinetics. Chronic ethanol abuse wreaks havoc on multiple organ systems, particularly the CNS and the liver. Abrupt cessation of ethanol...
610

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Understanding political perceptions of tobacco policies and stakeholders in France: A qualitative study with parliamentarians.

Tobacco prevention & cessation·2025
Same author

Turning tobacco Extended Producer Responsibility (EPR) into Extended Producer Liability (EPL): critical safeguards for the UN Plastics Treaty.

Tobacco control·2025
Same author

[Tobacco control in Switzerland : 60 years of gradual progress (1964-2024)].

Revue medicale suisse·2025
Same author

Soft Self-Regulating Heating Elements for Thermoplastic Elastomer-Based Electronic Skin Applications.

3D printing and additive manufacturing·2024
Same author

DNA-Based Replication of Programmable Colloidal Assemblies.

Small (Weinheim an der Bergstrasse, Germany)·2024
Same author

Lobbying against tobacco tax increases in France: arguments and strategies of the tobacco industry and tobacconists analysed through their trade press.

Tobacco control·2024

Related Experiment Video

Updated: Nov 1, 2025

A Microcontroller Operated Device for the Generation of Liquid Extracts from Conventional Cigarette Smoke and Electronic Cigarette Aerosol
09:30

A Microcontroller Operated Device for the Generation of Liquid Extracts from Conventional Cigarette Smoke and Electronic Cigarette Aerosol

Published on: January 18, 2018

8.5K

["Nicotine industry: risk reduction,an exclusively financial objective"].

Yves Martinet1, Emmanuelle Béguinot2, Pascal Diethelm3

  • 1Président du Comité d'éthique, CHRU Nancy, du Comité national contre le tabagisme et de Grand Est sans tabac - Comité national contre le tabagisme - "Unité de coordination de tabacologie, département de pneumologie, CHRU de Nancy, université de Lorraine, Vandoeuvre-lès-Nancy Cedex, France de tabacologie, département de pneumologie,CHRU de Nancy, université de Lorraine, Vandoeuvre-lès-Nancy Cedex, France".

La Revue Du Praticien
|June 23, 2021
PubMed
Summary

The tobacco industry promotes heat-not-burn products as harm reduction, but lacks independent scientific evidence. Marketing tactics target young people, bypassing current tobacco regulations.

Keywords:
Risk Reduction BehaviorTobacco Industry

More Related Videos

Methods to Evaluate Cytotoxicity and Immunosuppression of Combustible Tobacco Product Preparations
09:25

Methods to Evaluate Cytotoxicity and Immunosuppression of Combustible Tobacco Product Preparations

Published on: January 10, 2015

11.6K
Using Nicotine in a Silica-Exposed Mouse Model to Promote Lung Epithelial-Mesenchymal Transition
06:12

Using Nicotine in a Silica-Exposed Mouse Model to Promote Lung Epithelial-Mesenchymal Transition

Published on: March 3, 2023

975

Related Experiment Videos

Last Updated: Nov 1, 2025

A Microcontroller Operated Device for the Generation of Liquid Extracts from Conventional Cigarette Smoke and Electronic Cigarette Aerosol
09:30

A Microcontroller Operated Device for the Generation of Liquid Extracts from Conventional Cigarette Smoke and Electronic Cigarette Aerosol

Published on: January 18, 2018

8.5K
Methods to Evaluate Cytotoxicity and Immunosuppression of Combustible Tobacco Product Preparations
09:25

Methods to Evaluate Cytotoxicity and Immunosuppression of Combustible Tobacco Product Preparations

Published on: January 10, 2015

11.6K
Using Nicotine in a Silica-Exposed Mouse Model to Promote Lung Epithelial-Mesenchymal Transition
06:12

Using Nicotine in a Silica-Exposed Mouse Model to Promote Lung Epithelial-Mesenchymal Transition

Published on: March 3, 2023

975

Area of Science:

  • Public Health
  • Tobacco Control
  • Marketing and Business Strategy

Background:

  • The tobacco industry faces declining sales due to awareness of smoking's health effects and regulations.
  • To maintain profits, the industry seeks new markets and products, such as heat-not-burn (HNB) tobacco.
  • HNB products are presented as a harm reduction strategy, but lack independent scientific validation.

Purpose of the Study:

  • To critically evaluate the tobacco industry's 'harm reduction' claims regarding HNB products.
  • To analyze the marketing strategies employed by the industry to promote HNB products, particularly to young people.
  • To examine the regulatory landscape for HNB products compared to traditional smoked tobacco.

Main Methods:

  • Literature review of scientific evidence on HNB product safety and efficacy.
  • Analysis of industry-funded research and promotional materials.
  • Comparison of HNB regulations with those for smoked tobacco in France.

Main Results:

  • No independent scientific evidence supports HNB products as a harm reduction strategy.
  • The industry actively markets HNB products using various channels, including social media, targeting youth.
  • HNB products are often conflated with electronic cigarettes, creating consumer confusion.
  • Current French regulations for smoked tobacco do not apply to HNB products.

Conclusions:

  • The 'harm reduction' claims for HNB tobacco are primarily a financial strategy for the industry.
  • Industry marketing tactics, especially towards young people, raise significant public health concerns.
  • Regulatory loopholes for HNB products require urgent attention to protect public health.